InMed Pharmaceuticals (FRA:MWG) Debt-to-Asset : 0.10 (As of Sep. 2024)

InMed Pharmaceuticals Debt-to-Asset Chart

InMed Pharmaceuticals Annual Data
	Trend	Jun15	Jun16	Jun17	Jun18	Jun19	Jun20	Jun21	Jun22	Jun23	Jun24
Debt-to-Asset		Get a 7-Day Free Trial					0.04	0.03	0.06	0.03	0.08

InMed Pharmaceuticals Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Debt-to-Asset	Get a 7-Day Free Trial															0.03	0.08	0.08	0.08	0.10

Competitive Comparison of InMed Pharmaceuticals's Debt-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, InMed Pharmaceuticals's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

InMed Pharmaceuticals's Debt-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, InMed Pharmaceuticals's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where InMed Pharmaceuticals's Debt-to-Asset falls into.

InMed Pharmaceuticals Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

InMed Pharmaceuticals's Debt-to-Asset for the fiscal year that ended in Jun. 2024 is calculated as

InMed Pharmaceuticals's Debt-to-Asset for the quarter that ended in Sep. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

InMed Pharmaceuticals  (FRA:MWG) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

InMed Pharmaceuticals Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of InMed Pharmaceuticals's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

InMed Pharmaceuticals Business Description